Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
about
The expression of DNA methyltransferases3A is specifically downregulated in chorionic villi of early embryo growth arrest cases.Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia.Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal.Triglycerides/Glucose and Triglyceride/High-Density Lipoprotein Cholesterol Indices in Normal and Preeclamptic Pregnancies: A Longitudinal Study
P2860
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@ast
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@en
type
label
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@ast
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@en
prefLabel
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@ast
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@en
P2860
P1476
Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.
@en
P2093
Frank T Spradley
P2860
P304
P356
10.1152/AJPREGU.00440.2016
P577
2016-11-30T00:00:00Z